Paul Telfer

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga et al. · New England Journal of Medicine · 2019 · 609 citations · Full text

Medicine, Hematology, Hematopathology +8

Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia

Michael R. DeBaun, Mae O. Gordon, Robert C. McKinstry et al. · New England Journal of Medicine · 2014 · 537 citations · Full text

Medicine, Neurology, Pediatrics +17

American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults

Michael R. DeBaun, Lori C. Jordan, Allison A. King et al. · Blood Advances · 2020 · 417 citations · Full text

Medicine, Hematology, Pediatrics +17

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Haydar Frangoul, Franco Locatelli, Akshay Sharma et al. · New England Journal of Medicine · 2024 · 380 citations

Life Sciences, Genetics, Hematology +17

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

Geoffrey Dusheiko, Janice Main, H. C. Thomas et al. · Journal of Hepatology · 1996 · 352 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +15